Page last updated: 2024-10-26

donepezil and Esophageal Neoplasms

donepezil has been researched along with Esophageal Neoplasms in 1 studies

Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Fedorova, TD1
Knudsen, K1
Hartmann, B1
Holst, JJ1
Viborg Mortensen, F1
Krogh, K1
Borghammer, P1

Other Studies

1 other study available for donepezil and Esophageal Neoplasms

ArticleYear
In vivo positron emission tomography imaging of decreased parasympathetic innervation in the gut of vagotomized patients.
    Neurogastroenterology and motility, 2020, Volume: 32, Issue:3

    Topics: Aged; Carbon Radioisotopes; Donepezil; Esophageal Neoplasms; Esophagectomy; Female; Humans; Intestin

2020